Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

June is Alzheimer’s Awareness Month. Every 65 seconds, someone is diagnosed with Alzheimer’s disease. Right now, nearly 7 ...

The goal of this research is to determine whether benfotiamine, a synthetic version of thiamine or vitamin B1, is a treatment for mild cognitive impairment or early Alzheimer’s Disease.

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by ...

Rosemary is generally safe when used in food amounts, like sprinkled over chicken or in pasta, but rosemary supplements can ...

The RESTED-AD Study (Remote Evaluation of Sleep To Enhance Understanding in Early Dementia) investigated the effects of ...

Dementia is not a single disease — but rather a syndrome caused by various underlying conditions that damage the brain. The ...

A major global study tested whether European-derived polygenic risk scores (PGS) for Alzheimer’s disease can predict risk ...

A new study has shed light on how physical activity helps rewire and protect the brain from Alzheimer's disease on a cellular ...

For many years, astrocytes were seen as simple support cells in the brain. Today, that picture is changing fast.

Flies that expressed an Alzheimer’s disease-related protein in their neurons showed signs of accelerated aging.